Fatumo, S; Chikowore, T; Choudhury, A; Ayub, M; Martin, AR; Kuchenbaecker, K; (2022) A roadmap to increase diversity in genomic studies. Nature Medicine , 28 (2) pp. 243-250. 10.1038/s41591-021-01672-4.

Preview

Text Kuchenbaecker_Revised_Diversity in genomic studies1A[1].pdf Download (675kB) | Preview

Abstract

Two decades ago, the sequence of the first human genome was published. Since then, advances in genome technologies have resulted in whole-genome sequencing and microarray-based genotyping of millions of human genomes. However, genetic and genomic studies are predominantly based on populations of European ancestry. As a result, the potential benefits of genomic research—including better understanding of disease etiology, early detection and diagnosis, rational drug design and improved clinical care—may elude the many underrepresented populations. Here, we describe factors that have contributed to the imbalance in representation of different populations and, leveraging our experiences in setting up genomic studies in diverse global populations, we propose a roadmap to enhancing inclusion and ensuring equal health benefits of genomics advances. Our Perspective highlights the importance of sincere, concerted global efforts toward genomic equity to ensure the benefits of genomic medicine are accessible to all.

Download activity - last month

Export as JSONCSVXML

Download activity - last 12 months

Export as XMLCSVJSON

Downloads by country - last 12 months

Export as JSONCSVXML

Archive Staff Only

View Item